Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Site version updated from v3.4.3 to v3.5.0. The study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-03-21T19:15:29.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T07:36:05.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Minor revision note updated from v3.4.1 to v3.4.2; no user-facing content or functionality appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:58:40.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added Sarah Cannon Research Institute / Tennessee Oncology in Nashville, TN as a recruitment site; total study locations updated from 127 to 128.
    Difference
    0.2%
    Check dated 2026-02-06T09:12:53.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the page content and structure appear unchanged between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-29T20:09:56.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    UI updates add a Show/Hide glossary control and No FEAR Act data capitalization tweaks, along with Last Update fields and a new Revision: v3.4.0. These changes do not affect core study details or results.
    Difference
    0.2%
    Check dated 2026-01-22T17:45:14.000Z thumbnail image

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.